Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04907825
PHASE4

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

Sponsor: Cedars-Sinai Medical Center

View on ClinicalTrials.gov

Summary

This is a prospective, single-arm, feasibility pilot study of 20 participants (aged 60 years or older, with additional stroke risk factors and 'actionable' undertreated AF) recruited from a total of 4 retail and outpatient community pharmacies. Eligible participants will be enrolled in a 3-month active intervention of pharmacist-led OAC management. Participants will be passively followed for an additional 9 months to determine safety endpoints.

Official title: A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF (APOTHECARY AF Study)

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2023-03-13

Completion Date

2026-01-31

Last Updated

2026-08-10

Healthy Volunteers

Yes

Interventions

DRUG

Oral anticoagulant

Anticoagulant therapy will be initiated/titrated in patients with atrial fibrillation in accordance with ACC/AHA/HRS Guidelines

Locations (1)

Cedars-Sinai Medical Center

Los Angeles, California, United States